Review waiting, please be patient. This may take 4 months or more, since drafts are reviewed in no specific order. There are 3,040 pending submissions waiting for review. If the submission is accepted, then this page will be moved into the article space. If the submission is declined, then the reason will be posted here. In the meantime, you can continue to improve this submission by editing normally. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. How to improve a draft Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia. Help:Wikitext – how to use the markup Help:Referencing for beginners – how to include references Wikipedia:Article development – how to develop your article Wikipedia:Writing better articles – how to improve your article Wikipedia:Verifiability – make sure your article includes reliable third-party sources You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Add tags to your draft Editor resources Find sources:  Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Easy tools: Citation bot ( help) | Advanced: Fix bare URLs Reviewer tools Instructions · What links here · Anand Reddi ( talk:  + · bio) · ( log) · Copyvios report · reFill · Citation Bot · (Search:  Google,  Bing,  Wikipedia) · Submitted 24 days ago by Trex32 ( talk:  D · +) · Last edited 7 hours ago by Trex32

Anand Reddi is a global health policy researcher, HIV advocate and a member of the biotech industry focused on access to medicines. ^{[1] [2]} He is known for his scholarly and advocacy work on U.S. global health policy including the President's Emergency Plan for AIDS Relief (PEPFAR). ^{[3] [4] [5]} In 2005, Reddi was a Fulbright Scholar to South Africa on HIV/AIDS scale-up. ^[6]. He also was featured contributor on The Huffington Post writing on global health and U.S. domestic healthcare issues. ^[7]. Currently, he works in the biotech industry advancing global access to essential medicines and building public health partnerships. ^{[8] [9] [10]}

Early Life and Education

Reddi was born in Maryland, USA. He pursued his undergraduate studies at the University of Michigan, Ann Arbor. ^[11] Subsequently, he embarked on a Fulbright Scholarship to South Africa, focusing on pediatric antiretroviral scale-up in South Africa under the mentorship of Hoosen Coovadia. Reddi pursued a medical degree at the University of Colorado School of Medicine. ^{[12] [13]}

Global Health Contributions

In the early 2000s it was uncertain if the provision of antiretroviral therapy in resource limited settings such as Southern Africa was feasible. ^[14] Reddi's research resulted in one of the first implementation science studies that demonstrated that pediatric antiretroviral therapy is effective despite the challenges of a resource limited setting supporting initiatives underway by PEPFAR and The Global Fund. ^[15]. His work has appeared in AIDS, Journal of Acquired Immune Deficiency Syndromes and Science. He has also written opinion pieces in The Huffington Post, The New York Times and The Washington Post. ^[16]

Reddi's advocacy brought attention to the flatlining of global AIDS funding by U.S. President Barack Obama's administration in 2010. ^{[17] [18] [19] [20]} Within six hours, Ezekiel Emanuel, Obama's senior adviser for Health Policy, responded directly to Reddi by writing in The Huffington Post. ^[21] Reddi rebutted Emanuel's op-ed with a follow-up op-ed in The Huffington Post that resulted in the restoration of $366 million for antiretroviral scale-up in Uganda. ^[22]

In 2011, the AIDS Healthcare Foundation (AHF) launched a campaign against FDA review of Truvada for use as a HIV Pre-exposure Prophylaxis (PrEP) drug. ^[23] Reddi resigned from the Board of Directors of AHF in 2011 due to disagreements over AHF's opposition to HIV PrEP. ^[24] Reddi criticized AHF's claims against PrEP writing: "AHF’s media campaign against FDA review of PrEP is myopic, blinded by its determination to derail a promising new medication." ^[25] In 2015, the World Health Organization recommended that people at substantial risk of HIV infection should be offered tenofovir disoproxil fumarate (TDF)-based oral PrEP as an additional HIV prevention option. ^[26]

To address the shortage of healthcare workers in resource limited settings such as Southern and East Africa, Reddi was the first to propose the utilization of human capital contracts building on the work of the Noble Prize economics winner Milton Friedman. ^[27] This approach involves financing medical education in exchange for a commitment from students to serve in underserved areas upon graduation. ^[28]The idea proposed is that human capital contracts for global health is a mechanism in which an investor, such as a donor nation, charitable foundation, or global health initiative, will cover the entire cost of a student's medical training. In exchange, the student will work for the first 10 years of their medical career in a government or NGO sponsored health clinic in their respective country of medical education. Their medical license will be contingent on this obligatory national service. Additionally, a multilateral “binding” agreement between the African country and destination countries (such as Australia, Canada, New Zealand, United Kingdom, and the United States)-brokered by the investor- could prevent migration during the term period. ^[29]

At Gilead Sciences, Reddi spearheaded one of the largest HIV Test & Treat projects in collaboration with The Vatican in Shinyanga, Tanzania. ^{[30] [31]} The public private partnership between the biotech industry, the Vatican, Tanzanian government and HIV/AIDS NGOs such as Doctors with Africa CUAMM and Joep Lange's Amsterdam Institute of Global Health and Development pioneered a decentralized HIV test & treat outreach campaign to find at-risk populations, ultimately testing over 300,000 people and linking those HIV-positive to treatment. ^[32]. Outcomes from the Tanzania Test & Treat project between May 2017 and June 2019 were 255,329 HIV tests performed and the overall HIV positivity rate was 1.2%. ^[33]

References

Category:HIV/AIDS researchers Category:University of Michigan alumni Category:University of Colorado School of Medicine alumni Category:American scientists Category:Scientists from Maryland Category:21st-century scientists Category:Living people Category:Year of birth missing (living people) Category:American HIV/AIDS activists Category:American health activists